Close

Jefferies Downgrades Merck (MRK) to Hold

Go back to Jefferies Downgrades Merck (MRK) to Hold

Barclays Downgrades Merck (MRK) to Equalweight

October 14, 2013 10:07 AM EDT

Barclays downgraded Merck (NYSE: MRK) from Overweight to Equalweight.

For an analyst ratings summary and ratings history on Merck click here. For more ratings news on Merck click here.

Shares of Merck closed at $47.29 yesterday, with a 52 week range of $40.02-$50.16.... More

Jefferies Downgrades AstraZeneca (AZN) to Underperform

October 11, 2013 7:58 AM EDT

Jefferies downgraded AstraZeneca (NYSE: AZN) from Hold to Underperform and lowers its price target from 2,850.00p to 2,600.00p.

"We have downgraded AstraZeneca to Underperform from Hold as it is another strong bond proxy in our view with poor base business fundamentals," analyst... More